AdTab (previously Lotilaner Elanco) RSS Authorised This medicine is authorised for use in the European Union lotilaner Medicine Veterinary Authorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on AdTab (previously Lotilaner Elanco) Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine AdTab (previously Lotilaner Elanco) Active substance lotilaner International non-proprietary name (INN) or common name lotilaner Pharmacotherapeutic groupEctoparasiticides for systemic useIsoxazolines Authorisation details EMA product number EMEA/V/C/006030 Assessment history Expand section Collapse section Changes since initial authorisation of medicine CVMP post-authorisation summary of positive opinion for Lotilaner ElancoAdopted Reference Number: EMA/CVMP/42347/2023 English (EN) (123.02 KB - PDF)First published: 17/02/2023 View Initial marketing authorisation documents CVMP summary of positive opinion for Lotilaner ElancoAdopted Reference Number: EMA/CVMP/623416/2022 English (EN) (132.78 KB - PDF)First published: 15/07/2022 View News on AdTab (previously Lotilaner Elanco) Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 202512/09/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 18-19 June 202421/06/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-14 February 202416/02/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 202317/02/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-14 July 202215/07/2022 This page was last updated on 15/02/2024 Share this page